2022-04-012023-03-312023-03-31false06033696SAVING FACES LIMITED2023-10-18iso4217:GBPxbrli:pure060336962022-04-01060336962023-03-31060336962022-04-012023-03-31060336962021-04-01060336962022-03-31060336962021-04-012022-03-3106033696bus:SmallEntities2022-04-012023-03-3106033696bus:AuditExempt-NoAccountantsReport2022-04-012023-03-3106033696bus:FullAccounts2022-04-012023-03-3106033696bus:PrivateLimitedCompanyLtd2022-04-012023-03-3106033696core:WithinOneYear2023-03-3106033696core:AfterOneYear2023-03-3106033696core:WithinOneYear2022-03-3106033696core:AfterOneYear2022-03-3106033696core:ShareCapital2023-03-3106033696core:SharePremium2023-03-3106033696core:RevaluationReserve2023-03-3106033696core:OtherReservesSubtotal2023-03-3106033696core:RetainedEarningsAccumulatedLosses2023-03-3106033696core:ShareCapital2022-03-3106033696core:SharePremium2022-03-3106033696core:RevaluationReserve2022-03-3106033696core:OtherReservesSubtotal2022-03-3106033696core:RetainedEarningsAccumulatedLosses2022-03-3106033696core:LandBuildings2023-03-3106033696core:PlantMachinery2023-03-3106033696core:Vehicles2023-03-3106033696core:FurnitureFittings2023-03-3106033696core:OfficeEquipment2023-03-3106033696core:NetGoodwill2023-03-3106033696core:IntangibleAssetsOtherThanGoodwill2023-03-3106033696core:ListedExchangeTraded2023-03-3106033696core:UnlistedNon-exchangeTraded2023-03-3106033696core:LandBuildings2022-03-3106033696core:PlantMachinery2022-03-3106033696core:Vehicles2022-03-3106033696core:FurnitureFittings2022-03-3106033696core:OfficeEquipment2022-03-3106033696core:NetGoodwill2022-03-3106033696core:IntangibleAssetsOtherThanGoodwill2022-03-3106033696core:ListedExchangeTraded2022-03-3106033696core:UnlistedNon-exchangeTraded2022-03-3106033696core:LandBuildings2022-04-012023-03-3106033696core:PlantMachinery2022-04-012023-03-3106033696core:Vehicles2022-04-012023-03-3106033696core:FurnitureFittings2022-04-012023-03-3106033696core:OfficeEquipment2022-04-012023-03-3106033696core:NetGoodwill2022-04-012023-03-3106033696core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3106033696core:ListedExchangeTraded2022-04-012023-03-3106033696core:UnlistedNon-exchangeTraded2022-04-012023-03-3106033696core:MoreThanFiveYears2022-04-012023-03-3106033696core:Non-currentFinancialInstruments2023-03-3106033696core:Non-currentFinancialInstruments2022-03-3106033696dpl:CostSales2022-04-012023-03-3106033696dpl:DistributionCosts2022-04-012023-03-3106033696dpl:AdministrativeExpenses2022-04-012023-03-3106033696core:LandBuildings2022-04-012023-03-3106033696core:PlantMachinery2022-04-012023-03-3106033696core:Vehicles2022-04-012023-03-3106033696core:FurnitureFittings2022-04-012023-03-3106033696core:OfficeEquipment2022-04-012023-03-3106033696core:NetGoodwill2022-04-012023-03-3106033696core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3106033696dpl:GroupUndertakings2022-04-012023-03-3106033696dpl:ParticipatingInterests2022-04-012023-03-3106033696dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3106033696core:ListedExchangeTraded2022-04-012023-03-3106033696dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3106033696core:UnlistedNon-exchangeTraded2022-04-012023-03-3106033696dpl:CostSales2021-04-012022-03-3106033696dpl:DistributionCosts2021-04-012022-03-3106033696dpl:AdministrativeExpenses2021-04-012022-03-3106033696core:LandBuildings2021-04-012022-03-3106033696core:PlantMachinery2021-04-012022-03-3106033696core:Vehicles2021-04-012022-03-3106033696core:FurnitureFittings2021-04-012022-03-3106033696core:OfficeEquipment2021-04-012022-03-3106033696core:NetGoodwill2021-04-012022-03-3106033696core:IntangibleAssetsOtherThanGoodwill2021-04-012022-03-3106033696dpl:GroupUndertakings2021-04-012022-03-3106033696dpl:ParticipatingInterests2021-04-012022-03-3106033696dpl:GroupUndertakingscore:ListedExchangeTraded2021-04-012022-03-3106033696core:ListedExchangeTraded2021-04-012022-03-3106033696dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-04-012022-03-3106033696core:UnlistedNon-exchangeTraded2021-04-012022-03-3106033696core:NetGoodwill2023-03-3106033696core:IntangibleAssetsOtherThanGoodwill2023-03-3106033696core:LandBuildings2023-03-3106033696core:PlantMachinery2023-03-3106033696core:Vehicles2023-03-3106033696core:FurnitureFittings2023-03-3106033696core:OfficeEquipment2023-03-3106033696core:AfterOneYear2023-03-3106033696core:WithinOneYear2023-03-3106033696core:ListedExchangeTraded2023-03-3106033696core:UnlistedNon-exchangeTraded2023-03-3106033696core:ShareCapital2023-03-3106033696core:SharePremium2023-03-3106033696core:RevaluationReserve2023-03-3106033696core:OtherReservesSubtotal2023-03-3106033696core:RetainedEarningsAccumulatedLosses2023-03-3106033696core:NetGoodwill2022-03-3106033696core:IntangibleAssetsOtherThanGoodwill2022-03-3106033696core:LandBuildings2022-03-3106033696core:PlantMachinery2022-03-3106033696core:Vehicles2022-03-3106033696core:FurnitureFittings2022-03-3106033696core:OfficeEquipment2022-03-3106033696core:AfterOneYear2022-03-3106033696core:WithinOneYear2022-03-3106033696core:ListedExchangeTraded2022-03-3106033696core:UnlistedNon-exchangeTraded2022-03-3106033696core:ShareCapital2022-03-3106033696core:SharePremium2022-03-3106033696core:RevaluationReserve2022-03-3106033696core:OtherReservesSubtotal2022-03-3106033696core:RetainedEarningsAccumulatedLosses2022-03-3106033696core:NetGoodwill2021-04-0106033696core:IntangibleAssetsOtherThanGoodwill2021-04-0106033696core:LandBuildings2021-04-0106033696core:PlantMachinery2021-04-0106033696core:Vehicles2021-04-0106033696core:FurnitureFittings2021-04-0106033696core:OfficeEquipment2021-04-0106033696core:AfterOneYear2021-04-0106033696core:WithinOneYear2021-04-0106033696core:ListedExchangeTraded2021-04-0106033696core:UnlistedNon-exchangeTraded2021-04-0106033696core:ShareCapital2021-04-0106033696core:SharePremium2021-04-0106033696core:RevaluationReserve2021-04-0106033696core:OtherReservesSubtotal2021-04-0106033696core:RetainedEarningsAccumulatedLosses2021-04-0106033696core:AfterOneYear2022-04-012023-03-3106033696core:WithinOneYear2022-04-012023-03-3106033696core:Non-currentFinancialInstrumentscore:CostValuation2022-04-012023-03-3106033696core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-04-012023-03-3106033696core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-04-012023-03-3106033696core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-04-012023-03-3106033696core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-04-012023-03-3106033696core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-04-012023-03-3106033696core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3106033696core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3106033696core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3106033696core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3106033696core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3106033696core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3106033696core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3106033696core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3106033696core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3106033696core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3106033696core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3106033696core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3106033696core:Non-currentFinancialInstrumentscore:CostValuation2022-03-3106033696core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-3106033696core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-3106033696core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-3106033696core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-3106033696core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-3106033696core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-3106033696core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-3106033696core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-3106033696bus:Director12022-04-012023-03-3106033696bus:Director22022-04-012023-03-3106033696bus:Director32022-04-012023-03-3106033696core:FurnitureFittingsToolsEquipment2022-03-3106033696core:FurnitureFittingsToolsEquipment2022-04-012023-03-3106033696core:FurnitureFittingsToolsEquipment2023-03-31

SAVING FACES LIMITED

Registered Number
06033696
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2023

SAVING FACES LIMITED
Company Information
for the year from 1 April 2022 to 31 March 2023

Directors

HUSSAIN, Adam Jamal, Dr
HUSSAIN, Isaac, Dr
HUSSAIN, Jacqueline

Registered Address

Fulford Lodge 1 Heslington Lane
Fulford
York
YO10 4HW

Registered Number

06033696 (England and Wales)
SAVING FACES LIMITED
Statement of Financial Position
31 March 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets728,25913,477
28,25913,477
Current assets
Stocks94,3404,340
Debtors1027,7884,343
Cash at bank and on hand1,180,9831,148,743
1,213,1111,157,426
Creditors amounts falling due within one year11(972,177)(960,193)
Net current assets (liabilities)240,934197,233
Total assets less current liabilities269,193210,710
Creditors amounts falling due after one year12(13,897)-
Provisions for liabilities14(3,409)(170)
Net assets251,887210,540
Capital and reserves
Called up share capital11
Profit and loss account251,886210,539
Shareholders' funds251,887210,540
The financial statements were approved and authorised for issue by the Board of Directors on 18 October 2023, and are signed on its behalf by:
HUSSAIN, Adam Jamal, Dr
Director
HUSSAIN, Jacqueline
Director

Registered Company No. 06033696
SAVING FACES LIMITED
Notes to the Financial Statements
for the year ended 31 March 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Principal activities
The principal activity of the company during the year was that of a dental practice.
4.Basis of measurement used in financial statements
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
5.Accounting policies
Functional and presentation currency policy
The financial statements are presented in sterling and this is the functional currency of the company.
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
Stocks policy
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Revenue recognition policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year-end date is recognised by reference to the stage of completion.
Taxation policy
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax policy
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Leases policy
Assets held under finance leases and hire purchase contracts are recognised in the statement of financial position as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset. Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.
Employee benefits policy
Contributions to defined contribution plans are expensed in the period to which they relate.
Going concern
Following the challenges arising as a consequence of the Covid-19 pandemic in 2020/21, more latterly the UK economy has been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company’s trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it, and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
6.Employee information

20232022
Average number of employees during the year76
7.Property, plant and equipment

Land & buildings

Plant & machinery

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 April 22109,478176,726226,1451,170513,519
Additions-23,867-2,71626,583
At 31 March 23109,478200,593226,1453,886540,102
Depreciation and impairment
At 01 April 22109,478164,068226,145351500,042
Charge for year-11,219-58211,801
At 31 March 23109,478175,287226,145933511,843
Net book value
At 31 March 23-25,306-2,95328,259
At 31 March 22-12,658-81913,477
8.Description of nature of transactions and balances with related parties
The directors operate a directors loan account with the company. At 31 March 2023 the Company owed the directors £128 (2022: £128). This was the maximum outstanding during the year. This amount is repayable upon demand.
9.Stocks

2023

2022

££
Raw materials and consumables4,3404,340
Total4,3404,340
10.Debtors

2023

2022

££
Trade debtors / trade receivables10,9314,343
Other debtors2,200-
Prepayments and accrued income14,657-
Total27,7884,343
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
11.Creditors within one year

2023

2022

££
Trade creditors / trade payables61,67144,866
Amounts owed to related parties900,000900,000
Taxation and social security4,58912,776
Finance lease and HP contracts3,365-
Other creditors128128
Accrued liabilities and deferred income2,4242,423
Total972,177960,193
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
12.Creditors after one year

2023

2022

££
Other creditors13,897-
Total13,897-
13.Finance lease and HP contracts after one year

2023

2022

££
Finance lease and HP contracts13,897-
14.Provisions for liabilities

2023

2022

££
Net deferred tax liability (asset)3,409170
Total3,409170